Total marketcap
Total volume
BTC 51.60%     ETH 16.50%

Gilead Sciences GILD Stock

72.42 USD {{ price }} -1.482797% {{change_pct}}%
Market Cap
90.22B USD
LOW - HIGH [24H]
71.96 - 73.74 USD
2.14M USD
{{ volume }}
P/E Ratio
Earnings per share
0.36 USD

Gilead Sciences Price Chart

Gilead Sciences GILD Financial and Trading Overview

Gilead Sciences stock price 72.42 USD
Previous Close 78.93 USD
Open 79.2 USD
Bid 79.08 USD x 800
Ask 79.68 USD x 1000
Day's Range 79.16 - 80 USD
52 Week Range 72.87 - 88.29 USD
Volume 4.11M USD
Avg. Volume 6.2M USD
Market Cap 99.26B USD
Beta (5Y Monthly) 0.309
PE Ratio (TTM) 17.057816
EPS (TTM) 0.36 USD
Forward Dividend & Yield 3 (3.76%)
Ex-Dividend Date December 14, 2023
1y Target Est 80.98 USD

GILD Valuation Measures

Enterprise Value 116.2B USD
Trailing P/E 17.057816
Forward P/E 12.069697
PEG Ratio (5 yr expected) 3.43
Price/Sales (ttm) 3.6238017
Price/Book (mrq) 4.4517717
Enterprise Value/Revenue 4.242
Enterprise Value/EBITDA 9.899

Trading Information

Gilead Sciences Stock Price History

Beta (5Y Monthly) 0.309
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 88.29 USD
52 Week Low 72.87 USD
50-Day Moving Average 78.07 USD
200-Day Moving Average 78.24 USD

GILD Share Statistics

Avg. Volume (3 month) 6.2M USD
Avg. Daily Volume (10-Days) 7.93M USD
Shares Outstanding 1.25B
Float 1.24B
Short Ratio 2.71
% Held by Insiders 0.073%
% Held by Institutions 87.84%
Shares Short 17.42M
Short % of Float 1.55%
Short % of Shares Outstanding 1.39%

Dividends & Splits

Trailing Annual Dividend Rate 2.98
Trailing Annual Dividend Yield 3.77%
5 Year Average Dividend Yield 395.00%
Payout Ratio 0.6381
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) September 30, 2023
Next Fiscal Year End December 31, 2023


Profit Margin 21.45%
Operating Margin (ttm) 38.51%
Gross Margin 78.81%
EBITDA Margin 42.85%

Management Effectiveness

Return on Assets (ttm) 9.21%
Return on Equity (ttm) 26.92%

Income Statement

Revenue (ttm) 27.39B USD
Revenue Per Share (ttm) 21.9 USD
Quarterly Revenue Growth (yoy) 0.10%
Gross Profit (ttm) 21.62B USD
Net Income Avi to Common (ttm) 5.88B USD
Diluted EPS (ttm) 4.67
Quarterly Earnings Growth (yoy) 21.89%

Balance Sheet

Total Cash (mrq) 7.97B USD
Total Cash Per Share (mrq) 6.4 USD
Total Debt (mrq) 24.98B USD
Total Debt/Equity (mrq) 112.32 USD
Current Ratio (mrq) 1.338
Book Value Per Share (mrq) 17.894

Cash Flow Statement

Operating Cash Flow (ttm) 8.4B USD
Levered Free Cash Flow (ttm) 9.22B USD

Profile of Gilead Sciences

Country United States
State CA
City Foster City
Address 333 Lakeside Drive
ZIP 94404
Phone 650 574 3000
Website https://www.gilead.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 17000

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc., and Tentarix Biotherapeutics Inc., as well as a partnership with Assembly Biosciences, Inc. to develop next-generation therapeutics for serious viral diseases. The company was incorporated in 1987 and is headquartered in Foster City, California.

Q&A For Gilead Sciences Stock

What is a current GILD stock price?

Gilead Sciences GILD stock price today per share is 72.42 USD.

How to purchase Gilead Sciences stock?

You can buy GILD shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Gilead Sciences?

The stock symbol or ticker of Gilead Sciences is GILD.

Which industry does the Gilead Sciences company belong to?

The Gilead Sciences industry is Drug Manufacturers-General.

How many shares does Gilead Sciences have in circulation?

The max supply of Gilead Sciences shares is 1.25B.

What is Gilead Sciences Price to Earnings Ratio (PE Ratio)?

Gilead Sciences PE Ratio is 201.16666000 now.

What was Gilead Sciences earnings per share over the trailing 12 months (TTM)?

Gilead Sciences EPS is 0.36 USD over the trailing 12 months.

Which sector does the Gilead Sciences company belong to?

The Gilead Sciences sector is Healthcare.

Gilead Sciences GILD included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 17731.77 USD
2.76B USD 17691.43 USD 17935.14 USD 2.76B USD
S&P 500 (Yahoo.com) GSPC 5506.93 USD
1.34B USD 5497.04 USD 5557.5 USD 1.34B USD
S&P 500 INDEX SPX 5506.14 USD
1.29B USD 5497.04 USD 5557.5 USD 1.29B USD
S&P 100 SP100 2662.39 USD
745.66M USD 2657.02 USD 2690.96 USD 745.66M USD
US100 NDX 19524.18 USD
608.24M USD 19479.38 USD 19784.48 USD 608.24M USD
Dow Jones U.S. Biotechnology In DJUSBT 2879.89 USD
30.33M USD 2871.36 USD 2901.49 USD 30.33M USD
NASDAQ 100 Ex Tech Sector NDXX 5335.59 USD
5322.56 USD 5368.69 USD
Nasdaq-100 ESG JPY Index NDXESG07 2068.46 JPY 13.96 USD
2062.9 JPY 13.93 USD 2100.1 JPY 14.18 USD
NASDAQ-100 PM Settlement Value XQC 16331.98 USD
16331.98 USD 16331.98 USD
NASDAQ 100 Pre Market Indicator QMI 19707.26 USD
19682.8 USD 19745.5 USD
NASDAQ 100 Notional Net Total R XNDXNNR 22511.88 USD
22466.73 USD 22818.62 USD
NASDAQ Biotechnology NBI 4774.03 USD
4758.27 USD 4797.48 USD
NASDAQ OMX CRD Global Sustainab QCRD 1595.1 USD
Nasdaq-100 Micro Index XND 195.18 USD
194.79 USD 197.84 USD
NASDAQ HealthCare IXHC 1039.38 USD
1034.74 USD 1044.36 USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1495.45 USD
1489.01 USD 1499.82 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2670.69 USD
2667.59 USD 2686.42 USD
Nasdaq CRD Global Sustainabilit NQCRD 1735.62 USD
1715.94 USD 1757.95 USD
The Capital Strength Index seek NQCAPST 3114.39 USD
3110.36 USD 3150.03 USD
Nasdaq-100 ESG Net Notional Tot NDXESG24 1605.67 EUR 1755.21 USD
1602.23 EUR 1751.45 USD 1628 EUR 1779.63 USD